SER
AMEX
$2.18
AgeX Therapeutics Inc (SER)
Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology through its proprietary polymer-based drug delivery platform. This technology significantly enhances the efficacy of therapeutic agents, positioning Serina at the forefront of the biopharmaceutical industry. With a promising pipeline of product candidates and strategic partnerships, the company is well-equipped to drive sustainable growth and deliver impactful healthcare solutions, all while creating substantial value for its investors.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $9.50 (+335.78%)
Market Cap
$29M
Free Cash Flow Yield
-62.94%
Beta (5Y)
0.30
Price Chart
Valuation
Market Cap$29M
P/S224.96
P/B2.47
Profitability
Total Revenue (TTM)$130K
Gross Profit (TTM)-$13M
EBITDA-$25M
Operating Margin-18803%
EPS-$1.84
Financial Health
Free Cash Flow Yield-62.94%
Growth & Risk
EPS 5Y CAGR-28.62%
Revenue 5Y CAGR-12.88%
FCF 5Y CAGR+16.84%
Beta (5Y)0.30
Sharpe Ratio-0.12